UNIVERSITY OF WASHINGTON

Global rheumatoid arthritis incidence increased 13.2% from 1990 to 2021, affecting 17.9 million people worldwide by 2021, with significant regional disparities and a shift toward younger age groups.

Men experience higher mortality rates from 13 of the top 20 global health conditions, with COVID-19 and heart disease showing 45% higher illness and death rates compared to women.

Stanford Medicine researchers have developed a revolutionary blood test that analyzes cell-free RNA molecules to detect cancers at various stages, including early-stage lung cancer with 73% accuracy.

New AI technology developed at University of Washington has identified hundreds of undiagnosed fatty liver disease cases by analyzing existing imaging scans, with 83% of patients with evidence of the disease lacking formal diagnosis.

Recent research shows that ozone pollution exposure during a child's first two years increases asthma risk by 31% at ages 4-6, highlighting the need for long-term ozone regulation.

New research from Kaiser Permanente Southern California reveals wildfire smoke exposure significantly increases dementia risk, with each one-microgram-per-square-meter increase in wildfire-generated PM 2.5 associated with an 18% higher risk of dementia diagnosis.

Four out of five Americans are projected to be overweight or obese by 2050, with obesity rates increasing faster than overweight, according to a comprehensive study published in The Lancet.

New research identifies four critical limitations in comparing drug launch prices with value-based prices derived from conventional cost-effectiveness analyses, complicating policy decisions.

The Seqfirst-neo study reveals that using exclusion-based criteria for genomic testing in NICUs could significantly increase diagnosis rates, with 49.2% of tested infants receiving precise genetic diagnoses.

A systematic literature review presented at ASH 2024 demonstrates that clinical trials significantly underestimate the health-related quality of life burden in relapsed/refractory multiple myeloma patients compared to real-world settings.